SHA:600216

2 stories mentioning SHA:600216Updated 36d ago

Every FINWIRES story that references SHA:600216, newest first.

Zhejiang Medicine 2025 Profit Declines 25%; Shares Down 3%

Zhejiang Medicine (SHA:600216) posted 2025 attributable net profit of 873.4 million yuan, down 25% from 1.16 billion yuan the previous year.Earnings per share declined to 0.91 yuan from 1.21 yuan, according to a filing with the Shanghai bourse.Operating revenue slid 5.3% year over year to 8.88 billion yuan from 9.38 billion yuan.Shares of the pharmaceutical company were down 3% in recent trade.

SHA:600216

Asia64d ago

Zhejiang Medicine to Spin Off Subsidiary for Hong Kong Listing; Shares Down 4%

Zhejiang Medicine (SHA:600216) plans to spin off its subsidiary, Xinma Biopharmaceutical, for listing on the Hong Kong Stock Exchange, according to a Shanghai bourse filing on Saturday.The Chinese drugmaker's shares dropped less than 4% on Monday.

SHA:600216

Track with the FINWIRES app suite

FolioX

Track SHA:600216 in your portfolio

WheelAI

Analyze SHA:600216 options with the wheel strategy

StockInsider

See market sentiment on SHA:600216